Article
Brain Metabolic Profile in Presymptomatic GRN Carriers Throughout a 5-Year Follow-up.
Neurology - 24 Jan 2023
Saracino Dario, Sellami Leila, Boniface Hugo, Houot Marion, Pélégrini-Issac Mélanie, Funkiewiez Aurélie, Rinaldi Daisy, Locatelli Maxime, Azuar Carole, Causse-Lemercier Valérie, Jaillard Alice, Pasquier Florence, Chastan Mathieu, Wallon David, Hitzel Anne, Pariente Jérémie, Pallardy Amandine, Boutoleau-Bretonnière Claire, Guedj Eric, Didic Mira, Migliaccio Raffaella, Kas Aurélie, Habert Marie-Odile, Le Ber Isabelle
Abstract excerpt
BACKGROUND AND OBJECTIVES: GRN variants are a frequent cause of familial frontotemporal dementia (FTD). Monitoring disease progression in asymptomatic carriers of genetic variants is a major challenge in delivering preventative therapies before clinical onset. This study aimed to assess the usefulness of fluorodeoxyglucose (FDG)-PET in identifying metabolic changes in presymptomatic GRN carriers (PS-GRN+) and to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
